Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Ceapro Inc. (V:CZO)

Business Focus: Biotechnology & Medical Research

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for CZO within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Sep 14, 2020 08:35 ET
Ceapro Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced today that Gilles...
Read full article
Aug 20, 2020 09:05 ET
Ceapro Inc. Reports 2020 Second Quarter and Six-Month Financial Results and Operational Highlights
Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, today announced financial...
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
2.19
--
--
Price to Sales - TTM
3.49
14.83
10.20
Price to Book - most recent quarter
2.21
3.89
2.99
Price to Cash Flow per share - TTM
13.23
14.39
11.26
Price to Free Cash Flow per share - TTM
22.57
33.35
20.35
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 202012,5027,832
Aug 31, 20204,6703,670
Aug 15, 20201,000-29,165
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Ceapro Inc is a Canada-based biotechnology company. The Company's primary business activities relate to the development and marketing of various health and wellness products and technology relating to plant extracts. The Company is engaged in the development of proprietary extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Ceapro Inc supports the use of its extracts in cosmeceutical, nutraceutical and therapeutic products for humans and animals. The Company operates in one reportable business segment, being the operations relating to the active ingredient product technology industry. Ceapro Inc has a production facility in Leduc, Alberta, Canada and research laboratories in Edmonton and Charlottetown, Prince Edward Island, Canada.

See business summary

 

Twitter

Search (past week) for $CZO.CA CZO.V

  • No tweets found